N-[5-(3,5-DIFLUOROBENZYL)-1H-INDAZOL-3-YL]-4-(4-METHYL-PIPERAZIN-1-YL)-2-(TETRAHYDRO-2H-PYR… Application EP-3834827-A1 European Patent Office 16 Jun 2021
Pharmaceutical compositions and dosage forms Grant US-11007191-B2 United States of America 18 May 2021
Molecules for administration to ROS1 mutant cancer cells Grant US-10682348-B2 United States of America 16 Jun 2020
Compounds for treating patients with ROS1 mutant cancer cells Grant AU-2015220832-B2 Australia 27 Feb 2020
METHOD OF TREATING CANCER IN PATIENTS WITH MUTATIONS IN ROS1, NTRK1, NTRK2 AND/OR NTRK3… Application EA-033457-B1 Eurasian Patent Organisation 31 Oct 2019
Combinations for the treatment of neuroblastoma Grant US-10357490-B2 United States of America 23 Jul 2019
Molecules for administration to ROS1 mutant cancer cells Grant US-10231965-B2 United States of America 19 Mar 2019
Combinations for the treatment of neuroblastoma Grant US-10085979-B2 United States of America 02 Oct 2018
COMPOUNDS FOR TREATING PATIENTS WITH ROS1 MUTANT CANCER CELLS Application WO-2015124697-A1 World Intellectual Property Organisation (WIPO) 27 Aug 2015